Moreover, a correlation between S100A9 and calcium dysregulation in AD has been also evidenced since knockdown of S100A9 significantly diminished the increase of Ca2+ levels determined by APP C-terminal fragments or by Aβ (Ha et al., 2010). Here, S100A9 is linked to Alzheimer disease.